Who We Are
BioMarin is a global biotechnology company that relentlessly pursues bold science to translate genetic discoveries into new medicines that advance the future of human health.
Since our founding in 1997, we have applied our scientific expertise in understanding the underlying causes of genetic conditions to create transformative medicines, using a number of treatment modalities.
Using our unparalleled expertise in genetics and molecular biology, we develop medicines for patients with significant unmet medical need. We enlist the best of the best – people with the right technical expertise and a relentless drive to solve real problems – and create an environment that empowers our teams to pursue bold, innovative science. With this distinctive approach to drug discovery, we’ve produced a diverse pipeline of commercial, clinical and preclinical candidates that have well-understood biology and provide an opportunity to be first-to-market or offer a substantial benefit over existing therapeutic options.
About Worldwide Research and Development
From research and discovery to post-market clinical development, our WWRD engine involves all bench and clinical research and the associated groups that support those endeavors. Our teams work on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with genetic diseases.
SUMMARY
The Field Medical Manager istheexternal-facingscientificexpertonthecompanyproduct(s)andtherapeuticarea(s)with the coreresponsibilityofscientificengagement.Thisconsistsoftheestablishmentandmaintenance ofethicalandhighlyscientificpeertopeerrelationshipswithleadingHCPsatmajoracademicinstitutions and clinicsbased on high-quality response to medical inquiries and proactive engagement with leading HCPs through meaningful scientific exchange conducive to improved clinical management of patients.
RESPONSABILITIES
Scientific engagement
• Scientific engagement with KOLs in healthcare, academia, payer (as required), and government organizations (as required) to disseminate scientific information, gather insights and evaluate the expert opinion of KOLs. Thus, becoming a trusted scientific partner by enhancing the understanding of the scientific and medical value of BMRN products (pre- and post/at-launch)
• Proactive KOL mapping and planning according to the scientific strategic needs of the product or therapeutic area (pre- and post/at-launch)
• Development and implementation of Scientific Exchange meetings at hospital level. Support the Area/Country Director on the development and implementation of regional or national Scientific Educational Programs in line with BMRN’s scientific needs, including the scientific briefing of the speakers (pre- and post/at-launch)
• Conduct drug administration (infusion) readiness training upon request (post/at-launch)
• Support institution site readiness and perform on site drug risk-management drug education/information of post-marketing studies as required (post/at-launch).
• Scientific conference support (pre- and post/at-launch)
• Pre-conference
• Collaborate with colleagues to identify attending HCPs and arrange meetings with regional/global colleagues as necessary and/or scientific exchange meetings.
• During the conference
• Attending relevant scientific sessions.
• Engage in scientific exchange (ad-hoc, mostly pre- planned)
• Staff BMRN medical booths
• Post-conference
• Develop and deliver a full meeting report to be shared cross-functionally
• Prepare post-conference updates to not-attending HCPs
• Coordinate with Medical Information the provision of answers for on- or off- label queries (pre- and post/at-launch)
• Reactive provision of information to local PAGs in lieu of Area/Country Director in collaboration with Patient Advocacy (pre- and post/at-launch)
Support evidence generation
• Work with investigators in company sponsored studies supporting Clin Ops and/or Study Management resources by identifying potential study sites based on their scientific capabilities, administrative readiness, and stakeholder interests, proactively informing HCPs about sponsored trials to help recruit investigators, partnering with clinical operations and CROs to ensure surveillance and compliance with study programs, and proactively engaging with investigators both during startup and ongoing throughout the study to maintain interest in and education about the study (pre- and post/at-launch)
• Work with potential investigators supporting the development and submission of IIR proposals aligned with BMRN’s strategy (mostly post/at-launch)
• Reactive support to HCPs for assistance in providing scientific information for the development of audits or pathway redesign to improve healthcare quality and effectiveness initiatives (mostly post/at-launch)
• Identify further scientific research opportunities in the area that help increase disease awareness, sharing of best practices, and identification of medical gaps (mostly post/at- launch)
Insight management
• Share insights and knowledge from HCPs interactions with cross-functional team members: MSLs may proactively ask questions to understand the HCP’s scientific point of view on topics to share as insights for BMRN per Data protection laws (pre- and post/at-launch)
• Identify unmet medical needs and bring back the corresponding insights to the organization so they can be actioned accordingly by the relevant party (pre- and post-launch)
• Collect data and insights to understand patient and treatment journey (pre- and post- launch)
EDUCATION AND EXPERIENCE
Note: This description is not intended to be all-inclusive, or a limitation of the duties of the position. It is intended to describe the general nature of the job that may include other duties as assumed or assigned.
Equal Opportunity Employer/Veterans/Disabled
An Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability.